164 related articles for article (PubMed ID: 12752240)
1. Surveillance in stage I testicular cancer.
Daugaard G; Petersen PM; Rørth M
APMIS; 2003 Jan; 111(1):76-83; discussion 83-5. PubMed ID: 12752240
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.
Francis R; Bower M; Brunström G; Holden L; Newlands ES; Rustin GJ; Seckl MJ
Eur J Cancer; 2000 Oct; 36(15):1925-32. PubMed ID: 11000572
[TBL] [Abstract][Full Text] [Related]
3. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
4. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
[TBL] [Abstract][Full Text] [Related]
5. Clinical stage I testis cancer: long-term outcome of patients on surveillance.
Sogani PC; Perrotti M; Herr HW; Fair WR; Thaler HT; Bosl G
J Urol; 1998 Mar; 159(3):855-8. PubMed ID: 9474168
[TBL] [Abstract][Full Text] [Related]
6. Surveillance study for clinical stage I testicular seminomas and nonseminomatous germ cell tumors.
Suzuki K; Orikasa S; Hoshi S; Yoshikawa K; Imai Y; Aizawa M; Nishimura Y; Okada Y; Ohnuma T; Ogata Y
Int J Urol; 1998 Nov; 5(6):568-74. PubMed ID: 9855126
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
[TBL] [Abstract][Full Text] [Related]
8. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
9. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
11. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
12. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
13. "Burnt-out" testicular germ cell tumors.
Tynski Z; MacLennan GT
J Urol; 2005 Nov; 174(5):2013. PubMed ID: 16217383
[No Abstract] [Full Text] [Related]
14. Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
Osswald M; Harlan LC; Penson D; Stevens JL; Clegg LX
Urol Oncol; 2009; 27(6):604-10. PubMed ID: 18799329
[TBL] [Abstract][Full Text] [Related]
15. Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors.
Spermon JR; Roeleveld TA; van der Poel HG; Hulsbergen-van de Kaa CA; Ten Bokkel Huinink WW; van de Vijver M; Witjes JA; Horenblas S
Urology; 2002 Jun; 59(6):923-9. PubMed ID: 12031382
[TBL] [Abstract][Full Text] [Related]
16. An unusual late relapse in pathologic stage I non-seminomatous germ cell tumor: case report and review of the literature.
Bilgrami S; Chen L; Shafi N; Synnott V; Greenberg B
Urol Int; 1994; 53(3):176-8. PubMed ID: 7544042
[TBL] [Abstract][Full Text] [Related]
17. [Surveillance following orchiectomy for stage I testicular tumor].
Yonese J; Kawai T; Yamauchi T; Ueda T; Kawakami S; Ishibashi K
Nihon Hinyokika Gakkai Zasshi; 1993 Oct; 84(10):1804-10. PubMed ID: 8255043
[TBL] [Abstract][Full Text] [Related]
18. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of germ cell tumor after orchiectomy.
van der Poel HG; Sedelaar JP; Debruyne FM; Witjes JA
Urology; 2000 Sep; 56(3):467-73. PubMed ID: 10962317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]